ZYME FY 2022 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$412M+1446.0% YoY

Gross Profit

$412M100.0% margin

Operating Income

$131M31.6% margin

Net Income

$124M30.1% margin

EPS (Diluted)

$1.90

Cash Flow

Operating Cash Flow

$144M

Free Cash Flow

$131M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$649M

Total Liabilities

$156M

Stockholders' Equity

$493M

Cash & Equivalents

$401M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$412M	$27M	+1446.0%
Gross Profit	$412M	$27M	+1446.0%
Operating Income	$131M	-$216M	+160.5%
Net Income	$124M	-$212M	+158.7%